Alginate microencapsulation of human mesenchymal stem cells as a strategy to enhance paracrine-mediated vascular recovery after hindlimb ischaemia

Journal of Tissue Engineering and Regenerative Medicine

Volumn 10, Issue 3, 2016, Pages 222-232

  Landázuri, Natalia ^a   Levit, Rebecca D ^a   Joseph, Giji ^a   Ortega Legaspi, Juan Manuel ^a   Flores, Cristina A ^a   Weiss, Daiana ^a   Sambanis, Athanassios ^b,c   Weber, Collin J ^a   Safley, Susan A ^a   Taylor, W Robert ^a,b,d  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Emory University   (United States)

^c Georgia Institute of Technology   (United States)

^d ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

Cell therapy; Experimental models; in vivo tracking; Ischaemia; Mesenchymal stem cells; Paracrine; Revascularization; Tissue regeneration

Indexed keywords

ALGINATE; BIOCOMPATIBILITY; ENCAPSULATION; MOLECULAR BIOLOGY; PATIENT TREATMENT; STEM CELLS; TISSUE; TISSUE REGENERATION;

CELL THERAPY; CELL-BASED THERAPY; EXPERIMENTAL MODELLING; HUMAN MESENCHYMAL STEM CELLS; IN VIVO TRACKING; IN-VIVO; ISCHAEMIA; MESENCHYMAL STEM CELL; PARACRINE; REVASCULARIZATION;

CELL CULTURE;

ALGINIC ACID; ANGIOGENIN; ANGIOPOIETIN 2; FIBROBLAST GROWTH FACTOR 2; PLATELET DERIVED GROWTH FACTOR; SCATTER FACTOR; VASCULOTROPIN; GLUCURONIC ACID; HEXURONIC ACID; MICROCAPSULE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL ENCAPSULATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; HINDLIMB; HUMAN; HUMAN CELL; LIMB ISCHEMIA; LIMB PERFUSION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MICROCAPSULE; MICROENCAPSULATION; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; TISSUE REPAIR; ANIMAL; CYTOLOGY; DRUG EFFECTS; IMMOBILIZED CELL; ISCHEMIA; MESENCHYMAL STROMA CELL; NUDE MOUSE; PATHOLOGY; PERMEABILITY; VASCULARIZATION; WOUND HEALING;

ALGINATES; ANIMALS; CAPSULES; CELL SURVIVAL; CELLS, IMMOBILIZED; GLUCURONIC ACID; HEXURONIC ACIDS; HINDLIMB; HUMANS; ISCHEMIA; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE, NUDE; NEOVASCULARIZATION, PHYSIOLOGIC; PARACRINE COMMUNICATION; PERMEABILITY; WOUND HEALING;

EID: 84961217883     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1680     Document Type: Article

References (35)

1. Abdel-Latif A, Bolli R, Tleyjeh IM, et al. 2007; Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 167(10): 989-997.
2. Aggarwal S, Pittenger MF. 2005; Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105(4): 1815-1822.
3. Aicher A, Brenner W, Zuhayra M, et al. 2003; Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation 107(16): 2134-2139.
4. Armiñán A, Gandía C, García-Verdugo JM, et al. 2010; Mesenchymal stem cells provide better results than hematopoietic precursors for the treatment of myocardial infarction. J Am Coll Cardiol 55(20): 2244-2253.
5. Asahara T, Murohara T, Sullivan A, et al. 1997; Isolation of putative progenitor endothelial cells for angiogenesis. Science 275(5302): 964-967.
6. Augst AD, Kong HJ, Mooney DJ. 2006; Alginate hydrogels as biomaterials. Macromol Biosci 6(8): 623-633.
7. Black SP, Constantinidis I, Cui H, et al. 2006; Immune responses to an encapsulated allogeneic islet β cell line in diabetic NOD mice. Biochem Biophys Res Commun 340(1): 236-243.
8. Caplan AI, Dennis JE. 2006; Mesenchymal stem cells as trophic mediators. J Cell Biochem 98(5): 1076-1084.
9. Copland I, Sharma K, Lejeune L, et al. 2008; CD34 expression on murine marrow-derived mesenchymal stromal cells: impact on neovascularization. Exp Hematol 36(1): 93-103.
10. Duvivier-Kali VF, Omer A, Lopez-Avalos MD, et al. 2004; Survival of microencapsulated adult pig islets in mice in spite of an antibody response. Am J Transpl 4(12): 1991-2000.
11. Gnecchi M, He H, Liang OD, et al. 2005; Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 11(4): 367-368.
12. Gnecchi M, Zhang Z, Ni A, et al. 2008; Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 103(11): 1204-1219.
13. Goh F, Sambanis A. 2011; In vivo noninvasive monitoring of dissolved oxygen concentration within an implanted tissue-engineered pancreatic construct. Tissue Eng Part C Methods 17(9): 887-894.
14. Goren A, Dahan N, Goren E, et al. 2010; Encapsulated human mesenchymal stem cells: a unique hypoimmunogenic platform for long-term cellular therapy. FASEB J 24(1): 22-31.
15. Gupta R, Losordo DW. 2011; Cell therapy for critical limb ischemia: moving forward one step at a time. Circ Cardiovasc Interv 4(1): 2-5.
16. Hofmann M, Wollert KC, Meyer GP, et al. 2005; Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 111(17): 2198-2202.
17. Hou D, Youssef EA, Brinton TJ, et al. 2005; Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation 112(9, suppl): I150-156.
18. Janssens S, Dubois C, Bogaert J, et al. 2006; Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 367(9505): 113-121.
19. Kinnaird T, Stabile E, Burnett MS, et al. 2004a; Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94(5): 678-685.
20. Kinnaird T, Stabile E, Burnett MS, et al. 2004b; Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109(12): 1543-1549.
21. Laurila JP, Laatikainen L, Castellone MD, et al. 2009; Human embryonic stem cell-derived mesenchymal stromal cell transplantation in a rat hind limb injury model. Cytotherapy 11(6): 726-737.
22. Lawall H, Bramlage P, Amann B. 2011; Treatment of peripheral arterial disease using stem and progenitor cell therapy. J Vasc Surg 53(2): 445-453.
23. Meyerrose T, Olson S, Pontow S, et al. 2010; Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors. Adv Drug Deliv Rev 62(12): 1167-1174.
24. Mosna F, Sensebe L, Krampera M. 2010; Human bone marrow and adipose tissue mesenchymal stem cells: a user's guide. Stem Cells Dev 19(10): 1449-1470.
25. Peirone M, Ross CJ, Hortelano G, et al. 1998; Encapsulation of various recombinant mammalian cell types in different alginate microcapsules. J Biomed Mater Res 42(4): 587-596.
26. Rehman J, Traktuev D, Li J, et al. 2004; Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109(10): 1292-1298.
27. Safley SA, Cui H, Cauffiel S, et al. 2008; Biocompatibility and immune acceptance of adult porcine islets transplanted intraperitoneally in diabetic NOD mice in calcium alginate poly-l-lysine microcapsules versus barium alginate microcapsules without poly-l-lysine. J Diabetes Sci Technol 2(5): 760-767.
28. Safley SA, Kapp JA, Weber CJ. 2002; Proliferative and cytokine responses in CTLA4-Ig-treated diabetic NOD mice transplanted with microencapsulated neonatal porcine ICCs. Cell Transpl 11(7): 695-705.
29. Schachinger V, Erbs S, Elsasser A, et al. 2006; Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355(12): 1210-1221.
30. Silva SA, Sousa AL, Haddad AF, et al. 2009; Autologous bone-marrow mononuclear cell transplantation after acute myocardial infarction: comparison of two delivery techniques. Cell Transpl 18(3): 343-352.
31. Strand BL, Gaserod O, Kulseng B, et al. 2002; Alginate-polylysine-alginate microcapsules: effect of size reduction on capsule properties. J Microencapsul 19(5): 615-630.
32. Uccelli A, Moretta L, Pistoia V. 2008; Mesenchymal stem cells in health and disease. Nat Rev Immunol 8(9): 726-736.
33. Williams AR, Trachtenberg B, Velazquez DL, et al. 2011; Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling. Circ Res 108(7): 792-796.
34. Wojakowski W, Landmesser U, Bachowski R, et al. 2012; Mobilization of stem and progenitor cells in cardiovascular diseases. Leukemia 26(1): 23-33.
35. Ziegelhoeffer T, Fernandez B, Kostin S, et al. 2004; Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ Res 94(2): 230-238.